We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.13B
AUM Growth
+$133M
Cap. Flow
+$76.8M
Cap. Flow %
6.83%
Top 10 Hldgs %
29.98%
Holding
565
New
6
Increased
343
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$11.6M
2
IBN icon
ICICI Bank
IBN
+$6.87M
3
VZ icon
Verizon
VZ
+$6.14M
4
PANW icon
Palo Alto Networks
PANW
+$6.09M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.65M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$5.32M
2
AABA
Altaba Inc
AABA
+$4.73M
3
MGNX icon
MacroGenics
MGNX
+$3.45M
4
BAC icon
Bank of America
BAC
+$2.88M
5
RHT
Red Hat Inc
RHT
+$2.56M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Financials 18.55%
3 Consumer Discretionary 14.98%
4 Communication Services 14.5%
5 Healthcare 14.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
51
UnitedHealth
UNH
$371B
$5.01M 0.45%
25,600
+900
+4% +$174K
KO icon
52
Coca-Cola
KO
$374B
$4.93M 0.44%
109,600
+2,300
+2% +$105K
INTC icon
53
Intel
INTC
$492B
$4.81M 0.43%
126,300
+2,200
+2% +$78.2K
CMCSA icon
54
Comcast
CMCSA
$89.4B
$4.78M 0.42%
124,100
+2,500
+2% +$98.5K
HOLX
55
DELISTED
Hologic
HOLX
$4.64M 0.41%
126,600
-131,839
-51% -$5.32M
DD icon
56
DuPont de Nemours
DD
$19.1B
$4.33M 0.38%
24,691
+12,094
+96% +$2.02M
PEP icon
57
PepsiCo
PEP
$188B
$4.28M 0.38%
38,400
+800
+2% +$92.4K
INFY icon
58
Infosys
INFY
$50.9B
$4.12M 0.37%
565,200
+46,000
+9% +$348K
IIIN icon
59
Insteel Industries
IIIN
$626M
$4.1M 0.36%
157,042
+48,410
+45% +$1.31M
ORCL icon
60
Oracle
ORCL
$435B
$3.99M 0.35%
82,500
+1,600
+2% +$79.6K
VMW
61
DELISTED
VMware, Inc
VMW
$3.92M 0.35%
35,900
– –
JD icon
62
JD.com
JD
$45.2B
$3.85M 0.34%
100,900
+8,200
+9% +$351K
ABBV icon
63
AbbVie
ABBV
$438B
$3.79M 0.34%
42,600
+2,000
+5% +$152K
TEVA icon
64
Teva Pharmaceuticals
TEVA
$42.1B
$3.63M 0.32%
+206,483
New +$4.65M
AMGN icon
65
Amgen
AMGN
$226B
$3.58M 0.32%
19,200
+400
+2% +$70.9K
IBM icon
66
IBM
IBM
$223B
$3.51M 0.31%
25,313
+523
+2% +$72.9K
MA icon
67
Mastercard
MA
$493B
$3.5M 0.31%
24,800
+500
+2% +$66.2K
SPLK
68
DELISTED
Splunk Inc
SPLK
$3.43M 0.3%
51,600
+200
+0.4% +$12.5K
MCD icon
69
McDonald's
MCD
$194B
$3.41M 0.3%
21,750
-150
-0.7% -$23.5K
MMM icon
70
3M
MMM
$93.9B
$3.3M 0.29%
18,777
+359
+2% +$62.2K
NTES icon
71
NetEase
NTES
$85.4B
$3.19M 0.28%
60,500
+5,000
+9% +$287K
GILD icon
72
Gilead Sciences
GILD
$165B
$2.88M 0.26%
35,500
+700
+2% +$53.5K
FMX icon
73
Fomento Económico Mexicano
FMX
$40.9B
$2.88M 0.26%
30,100
+3,100
+11% +$309K
BMY icon
74
Bristol-Myers Squibb
BMY
$132B
$2.87M 0.26%
45,100
+900
+2% +$52.6K
USB icon
75
US Bancorp
USB
$100B
$2.45M 0.22%
45,800
+900
+2% +$47.1K
1 2
3
4 5

Similar funds

IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
SLI
Sumitomo Life Insurance Tokyo, Japan $4.25B AUM 23.69% 1-Year Est. Return

E. Ohman J:or Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, E. Ohman J:or Asset Management held 565 positions worth $1.13B, up 13% from $992M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

E. Ohman J:or Asset Management deployed $76.8M of net new capital in Q3 2017, opening 6 new positions and adding to 343 existing holdings. Its largest new stake was Teva Pharmaceuticals: 206,483 shares worth $3.63M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Hologic, an estimated $5.32M trimmed.

  • E. Ohman J:or Asset Management's largest Q3 2017 buy was Teva Pharmaceuticals: 206,483 shares worth $3.63M.
  • E. Ohman J:or Asset Management added most to Eli Lilly in Q3 2017, an estimated $11.6M increase.
  • E. Ohman J:or Asset Management's biggest Q3 2017 reduction was Hologic, cutting an estimated $5.32M.
  • E. Ohman J:or Asset Management fully exited MacroGenics in Q3 2017, selling an estimated $3.45M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 30% of its $1.13B portfolio in Q3 2017.
  • E. Ohman J:or Asset Management opened 6 new positions and closed 6 in Q3 2017.
  • E. Ohman J:or Asset Management's portfolio value rose 13% quarter-over-quarter to $1.13B.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2017, filed 5 Apr 2024.